We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+24.59%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$59.9B
AUM Growth
+$12.2B
(+25%)
Cap. Flow
+$2B
Cap. Flow
% of AUM
3.34%
Top 10 Holdings %
Top 10 Hldgs %
21.63%
Holding
3,213
New
281
Increased
1,628
Reduced
1,147
Closed
147
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$134M |
| 2 |
Microsoft
MSFT
|
+$119M |
| 3 |
Apple
AAPL
|
+$87.6M |
| 4 |
AbbVie
ABBV
|
+$61.7M |
| 5 |
Meta Platforms (Facebook)
META
|
+$54.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$92.9M |
| 2 |
RTN
Raytheon Company
RTN
|
+$71.6M |
| 3 |
CY
Cypress Semiconductor
CY
|
+$23.6M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$12.9M |
| 5 |
Domino's
DPZ
|
+$12.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.43% |
| 2 | Healthcare | 14.28% |
| 3 | Financials | 13.11% |
| 4 | Consumer Discretionary | 10.94% |
| 5 | Communication Services | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
Center Bancorp
CNOB
$1.78B
| $988K | ﹤0.01% |
61,290
+7,420
| +14% | +$106K |
|
2052
Evolent Health
EVH
$447M
| $986K | ﹤0.01% |
138,488
+14,480
| +12% | +$97K |
|
2053
Collegium Pharmaceutical
COLL
$956M
| $985K | ﹤0.01% |
56,299
+8,990
| +19% | +$176K |
|
|
DSPG
2054
DELISTED
DSP Group Inc
DSPG
| $984K | ﹤0.01% |
61,979
-7,905
| -11% | -$130K |
|
|
HTBK
2055
DELISTED
Heritage Commerce
HTBK
| $974K | ﹤0.01% |
129,765
+10,656
| +9% | +$83.5K |
|
2056
Brookdale Senior Living
BKD
$3.4B
| $969K | ﹤0.01% |
328,632
-10,252
| -3% | -$33.2K |
|
2057
V2X
VVX
$2.65B
| $967K | ﹤0.01% |
19,687
-488
| -2% | -$23.6K |
|
|
QUOT
2058
DELISTED
Quotient Technology Inc
QUOT
| $964K | ﹤0.01% |
131,745
-5,224
| -4% | -$35K |
|
2059
HCI Group
HCI
$2.41B
| $963K | ﹤0.01% |
20,863
-3,822
| -15% | -$166K |
|
|
EBSB
2060
DELISTED
Meridian Bancorp, Inc.
EBSB
| $963K | ﹤0.01% |
83,004
+6,761
| +9% | +$75.1K |
|
|
BMTC
2061
DELISTED
Bryn Mawr Bank Corp
BMTC
| $961K | ﹤0.01% |
34,746
-2,378
| -6% | -$64.6K |
|
|
RC
2062
Ready Capital
RC
$308M
| $960K | ﹤0.01% |
110,458
+3,026
| +3% | +$20.6K |
|
2063
Washington Trust Bancorp
WASH
$741M
| $958K | ﹤0.01% |
29,246
-1,504
| -5% | -$49.2K |
|
|
TBRG
2064
DELISTED
TruBridge
TBRG
| $958K | ﹤0.01% |
42,022
-3,124
| -7% | -$69.7K |
|
|
VCRA
2065
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $957K | ﹤0.01% |
45,122
+3,706
| +9% | +$72.6K |
|
2066
Quince Therapeutics
QNCX
$29.5M
| $956K | ﹤0.01% |
103
+35
| +51% | +$321K |
|
2067
Gorman-Rupp
GRC
$2.21B
| $955K | ﹤0.01% |
30,741
+2,133
| +7% | +$62.5K |
|
|
LBAI
2068
DELISTED
Lakeland Bancorp Inc
LBAI
| $952K | ﹤0.01% |
83,265
-4,232
| -5% | -$45.6K |
|
2069
Johnson Outdoors
JOUT
$505M
| $951K | ﹤0.01% |
10,449
+569
| +6% | +$40.7K |
|
2070
The Bancorp
TBBK
$2.84B
| $948K | ﹤0.01% |
96,692
+8,408
| +10% | +$63.3K |
|
|
ECOM
2071
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $946K | ﹤0.01% |
59,705
+6,420
| +12% | +$74.2K |
|
2072
El Pollo Loco
LOCO
$462M
| $940K | ﹤0.01% |
63,658
-9,443
| -13% | -$121K |
|
2073
ADT
ADT
$5.58B
| $937K | ﹤0.01% |
117,380
+1,185
| +1% | +$7.66K |
|
|
AERI
2074
DELISTED
Aerie Pharmaceuticals
AERI
| $935K | ﹤0.01% |
63,351
+3,593
| +6% | +$53.2K |
|
2075
AnaptysBio
ANAB
$1.68B
| $931K | ﹤0.01% |
41,656
+7,731
| +23% | +$141K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2020 Portfolio in Review
As of Q2 2020, RhumbLine Advisers held 3,213 positions worth $59.9B, up 25% from $47.7B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
RhumbLine Advisers deployed $2B of net new capital in Q2 2020, opening 281 new positions and adding to 1,628 existing holdings. Its largest new stake was Otis Worldwide: 701,378 shares worth $39.9M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares Core S&P Mid-Cap ETF, an estimated $12.9M trimmed.
- RhumbLine Advisers's largest Q2 2020 buy was Otis Worldwide: 701,378 shares worth $39.9M.
- RhumbLine Advisers added most to Amazon in Q2 2020, an estimated $134M increase.
- RhumbLine Advisers's biggest Q2 2020 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $12.9M.
- RhumbLine Advisers fully exited Allergan plc in Q2 2020, selling an estimated $92.9M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $59.9B portfolio in Q2 2020.
- RhumbLine Advisers opened 281 new positions and closed 147 in Q2 2020.
- RhumbLine Advisers's portfolio value rose 25% quarter-over-quarter to $59.9B.
Based on RhumbLine Advisers's 13F filing for Q2 2020, filed 13 Aug 2020.